AngioWaveNet vs Cleerly ISCHEMIA
AI Verdict
Choose AngioWaveNet if…
Choose AngioWaveNet if your primary need is to enhance fluoroscopic angiograms for improved vessel visualization directly within the cardiac catheterization laboratory workflow. This tool is ideal for optimizing image clarity during or immediately after interventional procedures, aiding clinicians in real-time decision-making and assessment of treatment efficacy.
View AngioWaveNet →Choose Cleerly ISCHEMIA if…
Choose Cleerly ISCHEMIA if you require a non-invasive, pre-procedural assessment of coronary artery ischemia and comprehensive plaque characterization from CCTA scans. This tool is best suited for personalized diagnosis and treatment planning, helping physicians determine the likelihood of ischemia at a vessel level before considering invasive interventions.
View Cleerly ISCHEMIA →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AngioWaveNet | Cleerly ISCHEMIA |
|---|---|---|
| Pricing | Pricing options include annual software licensing or subscription-based access, tailored to cath lab volume and hospital needs. custom packages are available. | Contact for details |
| Deployment | Cloud-based or on-premise/servers | Web-based platform; data transfer via Cleerly Proxy (VPN or virtual appliance) |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AngioWaveNetAngioWaveNet emphasizes a 'light footprint' in the hospital environment, integrating seamlessly as a post-processing AI into existing Cath lab workflows without requiring additional hardware. It boasts minimal training requirements and allows clinicians to review original and enhanced images side-by-side without delaying procedures.
Clinical Value
Cleerly ISCHEMIACleerly ISCHEMIA offers a more transformative clinical value by providing comprehensive, non-invasive diagnostic and prognostic information, including FFR estimation, plaque characterization, and ischemia likelihood, from CCTA scans. Its ability to predict future major adverse cardiovascular events and its validation through multiple clinical trials with invasive FFR as the gold standard demonstrate significant clinical utility.
Pricing & Value
Cleerly ISCHEMIACleerly ISCHEMIA provides clearer value due to its established Category I CPT code (75580) for non-invasive FFR estimation, which facilitates reimbursement and provides a defined billing pathway. While AngioWaveNet offers flexible licensing, the lack of specific pricing or reimbursement details makes its overall value proposition less transparent.
Enterprise Readiness
AngioWaveNetAngioWaveNet gains an edge in enterprise readiness by offering flexible deployment options (cloud-based or on-premise/servers), catering to a wider range of hospital IT infrastructure and security policies. Its vendor-agnostic compatibility and DICOM endpoint functionality also enhance its adaptability within diverse healthcare environments.
Innovation
Cleerly ISCHEMIACleerly ISCHEMIA demonstrates greater innovation by leveraging AI to non-invasively derive quantitative diagnostic and prognostic information, such as FFR estimation and detailed plaque characterization, from CCTA. This approach represents a significant advancement in diagnostic cardiology, potentially altering the patient care pathway and reducing the need for invasive procedures.
Support & Docs
AngioWaveNetAngioWaveNet explicitly details its 'full onboarding support, including installation assistance, staff training, and access to ongoing updates and clinical resources.' This comprehensive description of support services suggests a more robust and structured offering compared to Cleerly ISCHEMIA's general mention of client support.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AngioWaveNet | Cleerly ISCHEMIA |
|---|---|---|
| Tool Name | AngioWaveNet | Cleerly ISCHEMIA |
| Primary Use Case | Enhances fluoroscopic angiograms for improved vessel visualization in cardiac catheterization laboratories. | Analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level, aiding physicians in personalized diagnosis and treatment planning for heart disease. |
| Primary Imaging Modality Analyzed | Fluoroscopic angiograms | CCTA scans |
| Core AI Function/Enhancement | AI-powered Spatiotemporal Enhancement Processing (STEPu2122); improved vessel visualization; post-processing AI for angiographic images. | AI-enabled CCTA analysis; non-invasive fractional flow reserve (FFR) estimation; vessel-level ischemia likelihood determination; coronary plaque characterization; stenosis severity assessment. |
| Integration Capabilities | Integrates with existing Cath lab workflows; functions as a DICOM endpoint. | Integration with PowerScribe via API. |
| Vendor Compatibility | Compatible with any fluoroscopic angiography system (vendor-agnostic). | Not specified |
Videos
Demos, reviews, and walkthroughs featuring AngioWaveNet and Cleerly ISCHEMIA.
Frequently Asked Questions
More Comparisons
More matchups featuring AngioWaveNet or Cleerly ISCHEMIA
Backers
Who funded each tool's parent company.